Select a community
All Communities
Home > Community Treatment Reports > Zegerid Treatment Report
What is Zegerid?

Zegerid is a brand name for the drug Omeprazaole, a protein pump inhibitor used in the treatment of heartburn and gasto-oesophogeal reflex. Zegerid is a brand name owned by Santarus. Read more...Click to read more below

Santarus Inc.'s Zegerid site

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell
# of patients evaluated by
Acid reflux (GER gastroesophageal reflux) 4 2
Gastrointestinal Reflux Disease (GERD) 3 0
General health 2 0
Other 1 0
acid reflex 1 0

See all 12 patients currently taking Zegerid

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
2 100%

Dosages

  40mg-1100mg as needed 30 mg daily 20 mg-1100 mg daily 40 mg-1100 mg daily 2 x 40 mg-1100 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 7 Number of Patients: 7 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Zegerid (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 100% Did not seem to work: 100%
Course of treatment ended
1 100% Course of treatment ended: 100%

See all 1 patient who’ve stopped taking Zegerid

Currently Taking Zegerid

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Zegerid

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 50%
Not at all
1 50%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
2 100%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 21, 2010.